Bloomberg Businessweek
Bloomberg Markets: Nierengarten on Small, Mid-Market Biotech
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:11:00
- Mas informaciones
Informações:
Sinopsis
Bloomberg Markets with Carol Massar and Cory Johnson. GUEST: David Nierengarten Head of Health Care Equity Research Wedbush Securities Discussing investing in biotech stocks, inlcuding Blueprint Medicines.
